Metabolomic Laboratory-Developed Tests: Current Status and Perspectives.

Area of Science:

• Biotechnology
• Clinical Diagnostics
• Metabolomics

Background:

• Laboratory-developed tests (LDTs) are in vitro diagnostic devices manufactured and used within a single laboratory.
• The historical emergence and evolution of LDTs are examined.
• Metabolomics-based LDTs represent a significant advancement in diagnostic capabilities.

Purpose of the Study:

• To analyze the current state and future prospects of metabolomics-based LDTs.
• To elucidate the distinct features, advantages, and constraints of metabolomic LDTs compared to scientific metabolomics studies.
• To explore the potential for scaling metabolomic LDTs and their impact on healthcare.

Main Methods:

• Review of the literature on LDTs and metabolomics.
• Comparative analysis of metabolomic LDTs and scientific metabolomics studies.
• Examination of regulatory frameworks in the US, EU, and Singapore.

Main Results:

• Metabolomic LDTs possess unique characteristics, strengths, and limitations.
• Significant potential exists for the further development and scaling of metabolomic LDTs.
• Diverse regulatory approaches are evident across different global regions.

Conclusions:

• Metabolomic LDTs hold considerable promise for advancing healthcare diagnostics.
• Recommendations are provided for the practical implementation and expansion of metabolomic LDTs.
• Understanding the regulatory landscape is crucial for successful integration.